- Human（1）
No data
- His Tag（1）
No data
- HEK293（1）
No data
- Unconjugated（1）
No data
- RUO（1）
No data
- No（1）
No data
- 100ug/$360.00
- 1mg (500ug X 2)/$2380.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| NPTX2 | Human NPTX2 Protein, His Tag (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $360.00 100ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Paclitaxel/Hyaluronic acid | Phase 3 Clinical | Fidia Pharma | Carcinoma, Papillary; Urinary Bladder Neoplasms | Details | |
| Hydrogen peroxide/Hyaluronic acid | BMG-0703 | Phase 3 Clinical | University Of Milan | Periodontal Pocket; Bruxism; Gingival Hemorrhage; Gingivitis; Surgical Wound; Periodontitis | Details |
| CA-102N | CA-102N | Phase 2 Clinical | Biobud | Solid tumours; Colorectal Neoplasms | Details |
| Multiple 4SCAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Breast Neoplasms | Details | |
| AMT-116(Multitude Therapeutics) | AMT-116; AMT-116-ADC | Phase 2 Clinical | Multitude Therapeutics Inc | Solid tumours; Head and Neck Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| CD44v6-specific CAR gene-engineered T cell therapy (Shenzhen Geno-Immune Medical Institute) | 4SCAR-CD44v6 | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Neoplasms | Details |
| Hyaluronic acid/Fluorouracil | HA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complex | Phase 2 Clinical | Monash University, Alchemia Ltd | Colorectal Neoplasms | Details |
| AMC-303 | AMC-303; HP-558 | Phase 1 Clinical | Amcure Gmbh | Solid tumours; Esophageal Squamous Cell Carcinoma | Details |
| Clodronic acid/Hyaluronic acid | Phase 1 Clinical | Abiogen Pharma Spa | Osteoarthritis | Details | |
| YN-001 | YN001; YN-001 | Phase 1 Clinical | Beijing Inno Medicine Co Ltd | Plaque, Atherosclerotic; Atherosclerosis; Cerebrovascular Disorders; Cardiovascular Diseases | Details |
| BGC-0228 | BGC-0228 | Phase 1 Clinical | Solid tumours | Details | |
| Hyaluronic acid inhalation (Actelion Pharmaceuticals) | ETX-100; CTX-100 | Actelion Pharmaceuticals Ltd | Details |
